Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement.
Macchi Z, Wang Y, Moore D, Katz J, Saperstein D, Walk D, Simpson E, Genge A, Bertorini T, Fernandes JA, Swenson A, Elman L, Dimachkie M, Herbelin L, Miller J, Lu J, Wilkins H, Swerdlow RH, Statland J, Barohn R; Western ALS (WALS) Rasagiline Study Group. Macchi Z, et al. Among authors: elman l. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5-6):345-52. doi: 10.3109/21678421.2015.1026826. Epub 2015 Apr 2. Amyotroph Lateral Scler Frontotemporal Degener. 2015. PMID: 25832828 Free PMC article.
Cognitive reserve in ALS: The role of occupational skills and requirements.
Rhodes E, Alfa S, Jin H, Massimo L, Elman L, Amado D, Baer M, Quinn C, McMillan CT. Rhodes E, et al. Among authors: elman l. medRxiv [Preprint]. 2023 Jun 28:2023.06.21.23291677. doi: 10.1101/2023.06.21.23291677. medRxiv. 2023. Update in: Amyotroph Lateral Scler Frontotemporal Degener. 2024 Aug;25(5-6):486-495. doi: 10.1080/21678421.2024.2336113 PMID: 37425709 Free PMC article. Updated. Preprint.
Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
Young AL, Vogel JW, Robinson JL, McMillan CT, Ossenkoppele R, Wolk DA, Irwin DJ, Elman L, Grossman M, Lee VMY, Lee EB, Hansson O. Young AL, et al. Among authors: elman l. Brain. 2023 Jul 3;146(7):2975-2988. doi: 10.1093/brain/awad145. Brain. 2023. PMID: 37150879 Free PMC article.
Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum.
Shen T, Vogel JW, Duda J, Phillips JS, Cook PA, Gee J, Elman L, Quinn C, Amado DA, Baer M, Massimo L, Grossman M, Irwin DJ, McMillan CT. Shen T, et al. Among authors: elman l. Res Sq [Preprint]. 2023 Aug 10:rs.3.rs-3183113. doi: 10.21203/rs.3.rs-3183113/v1. Res Sq. 2023. Update in: Transl Neurodegener. 2023 Dec 7;12(1):57. doi: 10.1186/s40035-023-00389-3 PMID: 37609205 Free PMC article. Updated. Preprint.
Digital markers of motor speech impairments in natural speech of patients with ALS-FTD spectrum disorders.
Shellikeri S, Cho S, Ash S, Gonzalez-Recober C, McMillan CT, Elman L, Quinn C, Amado DA, Baer M, Irwin DJ, Massimo L, Olm C, Liberman M, Grossman M, Nevler N. Shellikeri S, et al. Among authors: elman l. medRxiv [Preprint]. 2023 May 1:2023.04.29.23289308. doi: 10.1101/2023.04.29.23289308. medRxiv. 2023. Update in: Amyotroph Lateral Scler Frontotemporal Degener. 2024 May;25(3-4):317-325. doi: 10.1080/21678421.2023.2288106 PMID: 37205390 Free PMC article. Updated. Preprint.
Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
Young AL, Vogel JW, Robinson JL, McMillan CT, Ossenkoppele R, Wolk DA, Irwin DJ, Elman L, Grossman M, Lee VM, Lee EB, Hansson O. Young AL, et al. Among authors: elman l. medRxiv [Preprint]. 2023 Feb 2:2023.01.31.23285242. doi: 10.1101/2023.01.31.23285242. medRxiv. 2023. Update in: Brain. 2023 Jul 3;146(7):2975-2988. doi: 10.1093/brain/awad145 PMID: 36778217 Free PMC article. Updated. Preprint.
Disparities in Genetic Testing for Neurologic Disorders.
Baldwin A, Copeland J, Azage M, Dratch L, Johnson K, Paul RA, Amado DA, Baer M, Deik A, Elman LB, Guo M, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn CC, Tropea TF, Scherer SS, Shinohara RT, Hamilton RH, Ellis CA. Baldwin A, et al. Among authors: elman lb. Neurology. 2024 Mar 26;102(6):e209161. doi: 10.1212/WNL.0000000000209161. Epub 2024 Mar 6. Neurology. 2024. PMID: 38447117
Genetic testing in adults with neurologic disorders: indications, approach, and clinical impacts.
Dratch L, Azage M, Baldwin A, Johnson K, Paul RA, Bardakjian TM, Michon SC, Amado DA, Baer M, Deik AF, Elman LB, Gonzalez-Alegre P, Guo MH, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn C, Tropea TF, Scherer SS, Ellis CA. Dratch L, et al. Among authors: elman lb. J Neurol. 2024 Feb;271(2):733-747. doi: 10.1007/s00415-023-12058-6. Epub 2023 Oct 27. J Neurol. 2024. PMID: 37891417 Free PMC article. Review.
Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum.
Shen T, Vogel JW, Duda J, Phillips JS, Cook PA, Gee J, Elman L, Quinn C, Amado DA, Baer M, Massimo L, Grossman M, Irwin DJ, McMillan CT. Shen T, et al. Among authors: elman l. Transl Neurodegener. 2023 Dec 7;12(1):57. doi: 10.1186/s40035-023-00389-3. Transl Neurodegener. 2023. PMID: 38062485 Free PMC article.
139 results